Epigenetic reprogramming and induced pluripotency.
paper
Cited
Public
Unavailable
- Authors
- Hochedlinger, Konrad; Plath, Kathrin
- Year
- 2009
- Journal
- Development (Cambridge, England)
- PMID
- 19168672
- DOI
- 10.1242/dev.020867
- PMCID
- PMC2685952
The cloning of animals from adult cells has demonstrated that the developmental state of adult cells can be reprogrammed into that of embryonic cells by uncharacterized factors within the oocyte. More recently, transcription factors have been identified that can induce pluripotency in somatic cells without the use of oocytes, generating induced pluripotent stem (iPS) cells. iPS cells provide a unique platform to dissect the molecular mechanisms that underlie epigenetic reprogramming. Moreover, iPS cells can teach us about principles of normal development and disease, and might ultimately facilitate the treatment of patients by custom-tailored cell therapy.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Induced Pluripotent Stem Cells in Birds: Opportunities and Challenges for Science and Agriculture. | Zahoor N et al. | β | 2024 | β |
| Manipulating cell fate through reprogramming: approaches and applications. | Yagi M et al. | β | 2024 | β |
| Ageing at Molecular Level: Role of MicroRNAs. | Yadav S et al. | β | 2023 | β |
| Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis. | OtΓ‘lora-OtΓ‘lora BA et al. | β | 2023 | β |
| PKI: A bioinformatics method of quantifying the importance of nodes in gene regulatory network via a pseudo knockout index. | Wang Y et al. | β | 2023 | β |
| Depletion of SMARCB1 and BRD7, two SWI/SNF chromatin remodelling complex subunits, differentially impact porcine embryo development. | Tseng YC et al. | β | 2022 | β |
| Direct chemical reprogramming of human cord blood erythroblasts to induced megakaryocytes that produce platelets. | Qin J et al. | β | 2022 | β |
| Probing cell identity hierarchies by fate titration and collision during direct reprogramming. | Hersbach BA et al. | β | 2022 | β |
| Tip60-mediated H2A.Z acetylation promotes neuronal fate specification and bivalent gene activation. | Janas JA et al. | β | 2022 | β |
| Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview. | Sundaravadivelu PK et al. | β | 2022 | β |
| Biological importance of OCT transcription factors in reprogramming and development. | Kim KP et al. | β | 2021 | β |
| Effects of electrical biostimulation and silver ions on porcine fibroblast cells. | Zhao Y et al. | β | 2021 | β |
| Embryonic Environmental Niche Reprograms Somatic Cells to Express Pluripotency Markers and Participate in Adult Chimaeras. | Ε»yΕΌyΕska-GaleΕska K et al. | β | 2021 | β |
| Epigenetic regulation of replication origin assembly: A role for histone H1 and chromatin remodeling factors. | Falbo L et al. | β | 2021 | β |
| Future Match Making: When Pediatric Oncology Meets Organoid Technology. | Barbet V et al. | β | 2021 | β |
| Gene expression analysis of human induced pluripotent stem cells cryopreserved by vitrification using StemCell Keep. | Ota A et al. | β | 2021 | β |
| Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling. | Liu C et al. | β | 2021 | β |
| Low dose lead exposure induces alterations on heterochromatin hallmarks persisting through SH-SY5Y cell differentiation. | Lin LF et al. | β | 2021 | β |
| Organoids in domestic animals: with which stem cells? | Pain B | β | 2021 | β |
| The FOXO signaling axis displays conjoined functions in redox homeostasis and stemness. | Soh R et al. | β | 2021 | β |
| Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells. | Baykal-KΓΆse S et al. | β | 2020 | β |
| Histone deacetylase inhibition promotes regenerative neurogenesis after stab wound injury in the adult zebrafish optic tectum. | Kiyooka M et al. | β | 2020 | β |
| Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation. | Shukla S et al. | β | 2020 | β |
| Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy. | Al Abbar A et al. | β | 2020 | β |
| Microscopic Chromosomal Structural and Dynamical Origin of Cell Differentiation and Reprogramming | Chu X et al. | β | 2020 | β |
| Microscopic Chromosomal Structural and Dynamical Origin of Cell Differentiation and Reprogramming. | Chu X et al. | β | 2020 | β |
| Rad50 mediates DNA demethylation to establish pluripotent reprogramming. | Park H et al. | β | 2020 | β |
| Small-molecule-mediated reprogramming: a silver lining for regenerative medicine. | Kim Y et al. | β | 2020 | β |
| SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters. | Lyu T et al. | β | 2020 | β |
| Transgenic F2 bovine embryos show stable germline transmission and maintenance of transgene expression through two generations. | Gim GM et al. | β | 2020 | β |
| Differential analysis of combinatorial protein complexes with CompleXChange. | Will T et al. | β | 2019 | β |
| Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs. | Velychko S et al. | β | 2019 | β |
| Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering. | Lawlor L et al. | β | 2019 | β |
| LncRNAs regulating stemness in aging. | Sousa-Franco A et al. | β | 2019 | β |
| Network Medicine in the Age of Biomedical Big Data. | Sonawane AR et al. | β | 2019 | β |
| Pancreatic endocrine-like cells differentiated from human umbilical cords Wharton's jelly mesenchymal stem cells using small molecules. | Belame Shivakumar S et al. | β | 2019 | β |
| Reprogramming: identifying the mechanisms that safeguard cell identity. | Brumbaugh J et al. | β | 2019 | β |
| Single cell RNA-seq identifies the origins of heterogeneity in efficient cell transdifferentiation and reprogramming. | Francesconi M et al. | β | 2019 | β |
| Targeting of apoptosis gene loci by reprogramming factors leads to selective eradication of leukemia cells. | Wang Y et al. | β | 2019 | β |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | β | 2019 | β |
| Cellular and Morpho-histological Foundations of In Vitro Plant Regeneration. | Rocha DI et al. | β | 2018 | β |
| Comparative in silico profiling of epigenetic modifiers in human tissues. | Son MY et al. | β | 2018 | β |
| Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells. | Luo Z et al. | β | 2018 | β |
| Imprinted gene Zinc finger protein 127 is a novel regulator of master pluripotency transcription factor, Oct4. | Kwon YW et al. | β | 2018 | β |
| let-7 MicroRNA-Mediated Regulation of Shh Signaling and the Gene Regulatory Network Is Essential for Retina Regeneration. | Kaur S et al. | β | 2018 | β |
| [Operative treatment of cartilage lesions]. | Rauch A et al. | β | 2018 | β |
| Telomere elongation upon transfer to callus culture reflects the reprogramming of telomere stability control in Arabidopsis. | SovΓ‘kovΓ‘ PP et al. | β | 2018 | β |
| The Clinical Use of Stem Cell Research in Chronic Obstructive Pulmonary Disease: A Critical Analysis of Current Policies. | Toraldo DM et al. | β | 2018 | β |
| Changing Stem Cell Dynamics during Papillomavirus Infection: Potential Roles for Cellular Plasticity in the Viral Lifecycle and Disease. | Strati K | β | 2017 | β |
| CSTEA: a webserver for the Cell State Transition Expression Atlas. | Zhu G et al. | β | 2017 | β |
| Current status in cancer cell reprogramming and its clinical implications. | Izgi K et al. | β | 2017 | β |
| Dnmt1 activity is dispensable in Ξ΄-cells but is essential for Ξ±-cell homeostasis. | Damond N et al. | β | 2017 | β |
| Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling. | Grzybek M et al. | β | 2017 | β |
| Evasion of host immune defenses by human papillomavirus. | Westrich JA et al. | β | 2017 | β |
| Genetically Encoded Photoactuators and Photosensors for Characterization and Manipulation of Pluripotent Stem Cells. | Pomeroy JE et al. | β | 2017 | β |
| Mechanism of human somatic reprogramming to iPS cell. | Teshigawara R et al. | β | 2017 | β |
| miR-6539 is a novel mediator of somatic cell reprogramming that represses the translation of Dnmt3b. | Wu F et al. | β | 2017 | β |
| Rational Design of Bisubstrate-Type Analogues as Inhibitors of DNA Methyltransferases in Cancer Cells. | Halby L et al. | β | 2017 | β |
| Rewiring of the inferred protein interactome during blood development studied with the tool PPICompare. | Will T et al. | β | 2017 | β |
| Bioinformatic and Genomic Analyses of Cellular Reprogramming and Direct Lineage Conversion. | Kareta MS | β | 2016 | β |
| Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. | Reece AS et al. | β | 2016 | β |
| Direct conversion of mouse embryonic fibroblasts into functional keratinocytes through transient expression of pluripotency-related genes. | Iacovides D et al. | β | 2016 | β |
| Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules. | Han YC et al. | β | 2016 | β |
| Dissecting Embryonic Stem Cell Self-Renewal and Differentiation Commitment from Quantitative Models. | Hu R et al. | β | 2016 | β |
| DNA Methylation in Skeletal Muscle Stem Cell Specification, Proliferation, and Differentiation. | Laker RC et al. | β | 2016 | β |
| Epigenetic modulation of dental pulp stem cells: implications for regenerative endodontics. | Duncan HF et al. | β | 2016 | β |
| Human regeneration: An achievable goal or a dream? | Ghosh S | β | 2016 | β |
| Induced Stem Cells as a Novel Multiple Sclerosis Therapy. | Xie C et al. | β | 2016 | β |
| iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System. | Orqueda AJ et al. | β | 2016 | β |
| OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition. | Teshigawara R et al. | β | 2016 | β |
| Oct4 Methylation-Mediated Silencing As an Epigenetic Barrier Preventing MΓΌller Glia Dedifferentiation in a Murine Model of Retinal Injury. | Reyes-Aguirre LI et al. | β | 2016 | β |
| Reprogramming towards endothelial cells for vascular regeneration. | Hong X et al. | β | 2016 | β |
| Selective de-repression of germ cell-specific genes in mouse embryonic fibroblasts in a permissive epigenetic environment. | Sekinaka T et al. | β | 2016 | β |
| Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking. | Goldman SA | β | 2016 | β |
| Tet3-Mediated DNA Demethylation Contributes to the Direct Conversion of Fibroblast to Functional Neuron. | Zhang J et al. | β | 2016 | β |
| The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent Mechanism. | Moore JB et al. | β | 2016 | β |
| The Only Constant Is Change: Next Generation Materials and Medical Device Design for Physical and Mental Health. | Knothe Tate ML et al. | β | 2016 | β |
| The Role of microRNAs in Animal Cell Reprogramming. | Cruz-Santos MC et al. | β | 2016 | β |
| Tissue-Specific Stem Cells Obtained by Reprogramming of Non-Obese Diabetic (NOD) Mouse-Derived Pancreatic Cells Confer Insulin Production in Response to Glucose. | Saitoh I et al. | β | 2016 | β |
| Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency. | van den Hurk M et al. | β | 2016 | β |
| Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients. | FernΓ‘ndez-Santiago R et al. | β | 2015 | β |
| A developmental framework for induced pluripotency. | Takahashi K et al. | β | 2015 | β |
| Cultural relativism: maintenance of genomic imprints in pluripotent stem cell culture systems. | Greenberg MV et al. | β | 2015 | β |
| Discovery of porcine maternal factors related to nuclear reprogramming and early embryo development by proteomic analysis. | Zhao Q et al. | β | 2015 | β |
| Efficient differentiation of steroidogenic and germ-like cells from epigenetically-related iPSCs derived from ovarian granulosa cells. | Anchan R et al. | β | 2015 | β |
| Enhanced conversion of induced neuronal cells (iN cells) from human fibroblasts: Utility in uncovering cellular deficits in mental illness-associated chromosomal abnormalities. | Passeri E et al. | β | 2015 | β |
| Environmental epigenetic inheritance through gametes and implications for human reproduction. | Wei Y et al. | β | 2015 | β |
| Epigenetic mechanisms of tumorigenicity manifesting in stem cells. | Tung PY et al. | β | 2015 | β |
| Epigenetic regulation of stemness maintenance in the neurogenic niches. | MontalbΓ‘n-Loro R et al. | β | 2015 | β |
| Functional screen reveals essential roles of miR-27a/24 in differentiation of embryonic stem cells. | Ma Y et al. | β | 2015 | β |
| Histone profiles in cancer. | Riedel SS et al. | β | 2015 | β |
| Leg regeneration is epigenetically regulated by histone H3K27 methylation in the cricket Gryllus bimaculatus. | Hamada Y et al. | β | 2015 | β |
| Making the first decision: lessons from the mouse. | Jedrusik A | β | 2015 | β |
| MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection. | Deng W et al. | β | 2015 | β |
| MicroRNAs and Cardiac Regeneration. | Hodgkinson CP et al. | β | 2015 | β |
| Modulation of Chromatin by Noncoding RNA. | Meller VH et al. | β | 2015 | β |
| Pluripotent stem cell-based models of spinal muscular atrophy. | Frattini E et al. | β | 2015 | β |
| Role of epigenetic reprogramming in hematopoietic stem cell function. | Iancu-Rubin C et al. | β | 2015 | β |
| Role of nanotechnology in epigenetic reprogramming. | Kadengodlu PA et al. | β | 2015 | β |
| The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. | Stivarou T et al. | β | 2015 | β |
| Transdifferentiation of Human Hair Follicle Mesenchymal Stem Cells into Red Blood Cells by OCT4. | Liu Z et al. | β | 2015 | β |
| Transdifferentiation via transcription factors or microRNAs: Current status and perspective. | Wang H et al. | β | 2015 | β |
| Tumoral reprogramming: Plasticity takes a walk on the wild side. | Campos-SΓ‘nchez E et al. | β | 2015 | β |
| Understanding the Molecular Basis of Heterogeneity in Induced Pluripotent Stem Cells. | Manian KV et al. | β | 2015 | β |
| Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors. | Planello AC et al. | β | 2014 | β |
| Activation-induced deaminase-coupled DNA demethylation is not crucial for the generation of induced pluripotent stem cells. | Habib O et al. | β | 2014 | β |
| An experimental approach to the generation of human embryonic stem cells equivalents. | Skowron K et al. | β | 2014 | β |
| Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. | Somoza RA et al. | β | 2014 | β |
| Classification of transient behaviours in a time-dependent toggle switch model. | Verd B et al. | β | 2014 | β |
| Delayed transition to new cell fates during cellular reprogramming. | Cheng X et al. | β | 2014 | β |
| Early environmental factors, alteration of epigenetic marks and metabolic disease susceptibility. | Portha B et al. | β | 2014 | β |
| Epigenetic choreography of stem cells: the DNA demethylation episode of development. | Kar S et al. | β | 2014 | β |
| Epigenetics, plasticity, and evolution: How do we link epigenetic change to phenotype? | Duncan EJ et al. | β | 2014 | β |
| Generation of induced pluripotent stem cells from mouse adipose tissue. | Goh PA et al. | β | 2014 | β |
| Glimpse into Hox and tale regulation of cell differentiation and reprogramming. | CerdΓ‘-Esteban N et al. | β | 2014 | β |
| Identifying transcription factor complexes and their roles. | Will T et al. | β | 2014 | β |
| Impact of epigenetic dietary compounds on transgenerational prevention of human diseases. | Li Y et al. | β | 2014 | β |
| Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. | Lalit PA et al. | β | 2014 | β |
| Induced pluripotent stem cell technology and aquatic animal species. | Temkin AM et al. | β | 2014 | β |
| Micro-management of pluripotent stem cells. | Guo WT et al. | β | 2014 | β |
| MΓΌller glia: Stem cells for generation and regeneration of retinal neurons in teleost fish. | Lenkowski JR et al. | β | 2014 | β |
| Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons. | Talluri TR et al. | β | 2014 | β |
| Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons. | Qi SD et al. | β | 2014 | β |
| Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons. | Qi SD et al. | β | 2014 | β |
| Overexpression of cyclin dependent kinase inhibitor P27/Kip1 increases oligodendrocyte differentiation from induced pluripotent stem cells. | Tamaki S et al. | β | 2014 | β |
| Pioneer transcription factors in cell reprogramming. | Iwafuchi-Doi M et al. | β | 2014 | β |
| Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration. | He WJ et al. | β | 2014 | β |
| Positive correlation between the efficiency of induced pluripotent stem cells and the development rate of nuclear transfer embryos when the same porcine embryonic fibroblast lines are used as donor cells. | Xie B et al. | β | 2014 | β |
| Reprogramming cancer cells to pluripotency: an experimental tool for exploring cancer epigenetics. | Stricker S et al. | β | 2014 | β |
| Reprogramming the methylome: erasing memory and creating diversity. | Lee HJ et al. | β | 2014 | β |
| Single cell analysis reveals the stochastic phase of reprogramming to pluripotency is an ordered probabilistic process. | Chung KM et al. | β | 2014 | β |
| Small molecule compound induces chromatin de-condensation and facilitates induced pluripotent stem cell generation. | Wei X et al. | β | 2014 | β |
| Somatic cells, stem cells, and induced pluripotent stem cells: how do they now contribute to conservation? | Mastromonaco GF et al. | β | 2014 | β |
| The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes. | Urvalek A et al. | β | 2014 | β |
| Two miRNA clusters reveal alternative paths in late-stage reprogramming. | Parchem RJ et al. | β | 2014 | β |
| A blueprint for engineering cell fate: current technologies to reprogram cell identity. | Morris SA et al. | β | 2013 | β |
| Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells. | Hong SG et al. | β | 2013 | β |
| Breaking through an epigenetic wall: re-activation of Oct4 by KRAB-containing designer zinc finger transcription factors. | JuΓ‘rez-Moreno K et al. | β | 2013 | β |
| Changes in RNA polymerase II progression influence somatic hypermutation of Ig-related genes by AID. | Kodgire P et al. | β | 2013 | β |
| Chemical genetics and its potential in cardiac stem cell therapy. | Vieira JM et al. | β | 2013 | β |
| Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells. | Verpelli C et al. | β | 2013 | β |
| Conversion of genomic imprinting by reprogramming and redifferentiation. | Kim MJ et al. | β | 2013 | β |
| Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. | Hendry CE et al. | β | 2013 | β |
| DNA repair mechanisms in Huntington's disease. | Jonson I et al. | β | 2013 | β |
| Dynamic migration and cell-cell interactions of early reprogramming revealed by high-resolution time-lapse imaging. | Megyola CM et al. | β | 2013 | β |
| Epidermal stem cells: an update on their potential in regenerative medicine. | Sun X et al. | β | 2013 | β |
| Epigenetic memory in the context of nuclear reprogramming and cancer. | Halley-Stott RP et al. | β | 2013 | β |
| Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. | Watanabe A et al. | β | 2013 | β |
| Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. | Lee MR et al. | β | 2013 | β |
| Epigenetic targeting therapies to overcome chemotherapy resistance. | Balch C et al. | β | 2013 | β |
| Evaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cells. | Bhise NS et al. | β | 2013 | β |
| Feeder-independent culture systems for human pluripotent stem cells. | Moody J | β | 2013 | β |
| Foundational concepts of cell fate conversion to the hematopoietic lineage. | Salci KR et al. | β | 2013 | β |
| FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy. | Wierstra I | β | 2013 | β |
| Generation of transgene-free induced pluripotent stem cells with non-viral methods. | Wang T et al. | β | 2013 | β |
| Genome damage in induced pluripotent stem cells: assessing the mechanisms and their consequences. | Hussein SM et al. | β | 2013 | β |
| Homologous recombination DNA repair genes play a critical role in reprogramming to a pluripotent state. | GonzΓ‘lez F et al. | β | 2013 | β |
| Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs. | Yang CS et al. | β | 2013 | β |
| MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. | Gaspar-Maia A et al. | β | 2013 | β |
| microRNA-29b is a novel mediator of Sox2 function in the regulation of somatic cell reprogramming. | Guo X et al. | β | 2013 | β |
| Modeling stem cell induction processes. | GrΓ‘cio F et al. | β | 2013 | β |
| Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. | Folmes CD et al. | β | 2013 | β |
| Pluripotent genes in avian stem cells. | Jean C et al. | β | 2013 | β |
| Programming of respiratory health in childhood: influence of outdoor air pollution. | Wright RJ et al. | β | 2013 | β |
| Regulation of Pluripotency-related Genes and Differentiation in Mouse Embryonic Stem Cells by Direct Delivery of Cell-penetrating Peptide-conjugated CARM1 Recombinant Protein. | Choi S et al. | β | 2013 | β |
| Reprogramming to pluripotency using designer TALE transcription factors targeting enhancers. | Gao X et al. | β | 2013 | β |
| Resetting epigenetic signatures to induce somatic cell reprogramming. | Lluis F et al. | β | 2013 | β |
| SNF5 is an essential executor of epigenetic regulation during differentiation. | You JS et al. | β | 2013 | β |
| Stem cells for reprogramming: could hUMSCs be a better choice? | Duya P et al. | β | 2013 | β |
| Structure of the transcriptional network controlling white-opaque switching in Candida albicans. | Hernday AD et al. | β | 2013 | β |
| The choice of expression vector promoter is an important factor in the reprogramming of porcine fibroblasts into induced pluripotent cells. | Petkov S et al. | β | 2013 | β |
| The epigenetic landscape in the course of time: Conrad Hal Waddington's methodological impact on the life sciences. | Baedke J | β | 2013 | β |
| The evolving field of induced pluripotency: recent progress and future challenges. | Sommer CA et al. | β | 2013 | β |
| The future of epigenetic therapy in solid tumours--lessons from the past. | Azad N et al. | β | 2013 | β |
| The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming. | Marzi I et al. | β | 2013 | β |
| The Osa-containing SWI/SNF chromatin-remodeling complex regulates stem cell commitment in the adult Drosophila intestine. | Zeng X et al. | β | 2013 | β |
| The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles. | Wierstra I | β | 2013 | β |
| Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules. | Blancafort P et al. | β | 2013 | β |
| Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation. | Jiang J et al. | β | 2013 | β |
| Active DNA demethylation in mammalian preimplantation embryos: new insights and new perspectives. | Ma JY et al. | β | 2012 | β |
| A novel small molecule facilitates the reprogramming of human somatic cells into a pluripotent state and supports the maintenance of an undifferentiated state of human pluripotent stem cells. | Lee J et al. | β | 2012 | β |
| Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy. | Aguila JC et al. | β | 2012 | β |
| Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells. | Kim SY et al. | β | 2012 | β |
| Concise review: Human cell engineering: cellular reprogramming and genome editing. | Mali P et al. | β | 2012 | β |
| Delineating nuclear reprogramming. | Ooi J et al. | β | 2012 | β |
| Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. | Ring KL et al. | β | 2012 | β |
| Efficient derivation of bovine embryonic stem cells needs more than active core pluripotency factors. | Maruotti J et al. | β | 2012 | β |
| Energy metabolism plasticity enables stemness programs. | Folmes CDL et al. | β | 2012 | β |
| Enhancers as information integration hubs in development: lessons from genomics. | Buecker C et al. | β | 2012 | β |
| Epigenetic landscape of pluripotent stem cells. | Han JW et al. | β | 2012 | β |
| Epigenetics of embryonic stem cells. | Calvanese V et al. | β | 2012 | β |
| From pluripotency to distinct cardiomyocyte subtypes. | David R et al. | β | 2012 | β |
| Generation of induced pluripotent stem cells from mouse cancer cells. | Lin FK et al. | β | 2012 | β |
| Genomic stability in reprogramming. | Ronen D et al. | β | 2012 | β |
| Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming. | Kretsovali A et al. | β | 2012 | β |
| Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. | Jung YW et al. | β | 2012 | β |
| Hydrodynamic modulation of pluripotent stem cells. | Fridley KM et al. | β | 2012 | β |
| Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth. | Yin L et al. | β | 2012 | β |
| Jak/Stat3 signaling promotes somatic cell reprogramming by epigenetic regulation. | Tang Y et al. | β | 2012 | β |
| Limited dedifferentiation provides replacement tissue during zebrafish fin regeneration. | Stewart S et al. | β | 2012 | β |
| Malglycemia and cancer: introduction to a conceptual model. | Hammer MJ et al. | β | 2012 | β |
| Microvesicles in health and disease. | Inal JM et al. | β | 2012 | β |
| Model systems for studying trophoblast differentiation from human pluripotent stem cells. | Ezashi T et al. | β | 2012 | β |
| Molecular roadblocks for cellular reprogramming. | Vierbuchen T et al. | β | 2012 | β |
| Nucleosome stability dramatically impacts the targeting of somatic hypermutation. | Kodgire P et al. | β | 2012 | β |
| Nucleostemin maintains self-renewal of embryonic stem cells and promotes reprogramming of somatic cells to pluripotency. | Qu J et al. | β | 2012 | β |
| Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives. | Lui KO et al. | β | 2012 | β |
| Pre-procambial cells are niches for pluripotent and totipotent stem-like cells for organogenesis and somatic embryogenesis in the peach palm: a histological study. | de Almeida M et al. | β | 2012 | β |
| Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer. | Strauss R et al. | β | 2012 | β |
| Reprogramming the kidney: a novel approach for regeneration. | Hendry CE et al. | β | 2012 | β |
| Research on neurodegenerative diseases using induced pluripotent stem cells. | Imamura K et al. | β | 2012 | β |
| Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential. | Darini CY et al. | β | 2012 | β |
| Stem cells in the treatment of cardiovascular disease--an overview. | Hotkar AJ et al. | β | 2012 | β |
| Strategies to modulate heritable epigenetic defects in cellular machinery: lessons from nature. | Pandian GN et al. | β | 2012 | β |
| Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling. | Zong Y et al. | β | 2012 | β |
| Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. | Stolzenburg S et al. | β | 2012 | β |
| Uncoupled embryonic and extra-embryonic tissues compromise blastocyst development after somatic cell nuclear transfer. | Degrelle SA et al. | β | 2012 | β |
| Variability in the generation of induced pluripotent stem cells: importance for disease modeling. | Vitale AM et al. | β | 2012 | β |
| Wnt pathway regulation of embryonic stem cell self-renewal. | Merrill BJ | β | 2012 | β |
| 2D difference gel electrophoresis analysis of different time points during the course of neoplastic transformation of human mammary epithelial cells. | DeAngelis JT et al. | β | 2011 | β |
| A deterministic map of Waddington's epigenetic landscape for cell fate specification. | Bhattacharya S et al. | β | 2011 | β |
| Adipogenic histone mark regulation by matrix metalloproteinase 14 in collagen-rich microenvironments. | Sato-Kusubata K et al. | β | 2011 | β |
| Association of telomere length with authentic pluripotency of ES/iPS cells. | Huang J et al. | β | 2011 | β |
| Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. | Martino G et al. | β | 2011 | β |
| Cell cycle adaptations and maintenance of genomic integrity in embryonic stem cells and induced pluripotent stem cells. | MomΔiloviΔ O et al. | β | 2011 | β |
| Chromatin modification in zebrafish development. | Cayuso Mas J et al. | β | 2011 | β |
| Chromatin regulation landscape of embryonic stem cell identity. | Lee YH et al. | β | 2011 | β |
| Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells. | Pournasr B et al. | β | 2011 | β |
| Convergence of normal stem cell and cancer stem cell developmental stage: Implication for differential therapies. | Li SC et al. | β | 2011 | β |
| Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. | Efe JA et al. | β | 2011 | β |
| Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation. | Chhabra P et al. | β | 2011 | β |
| Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. | Jopling C et al. | β | 2011 | β |
| De novo DNA methylation by Dnmt3a and Dnmt3b is dispensable for nuclear reprogramming of somatic cells to a pluripotent state. | Pawlak M et al. | β | 2011 | β |
| Development of feeder-free culture systems for generation of ckit+sca1+ progenitors from mouse iPS cells. | Lin J et al. | β | 2011 | β |
| Direct lineage conversions: unnatural but useful? | Vierbuchen T et al. | β | 2011 | β |
| Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. | Ghosh Z et al. | β | 2011 | β |
| Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered. | Desmet VJ | β | 2011 | β |
| E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. | Redmer T et al. | β | 2011 | β |
| Efficient generation of fully reprogrammed human iPS cells via polycistronic retroviral vector and a new cocktail of chemical compounds. | Zhang Z et al. | β | 2011 | β |
| Endothelial and cardiac progenitors: boosting, conditioning and (re)programming for cardiovascular repair. | Pesce M et al. | β | 2011 | β |
| Epigenetic factors influencing resistance to nuclear reprogramming. | Pasque V et al. | β | 2011 | β |
| Epigenetic regulation in cell reprogramming revealed by genome-wide analysis. | Hong CP et al. | β | 2011 | β |
| Epigenomics of human embryonic stem cells and induced pluripotent stem cells: insights into pluripotency and implications for disease. | Rada-Iglesias A et al. | β | 2011 | β |
| FOXP3 Expression in GARP-Transduced Helper T Cells Is Not Associated with FOXP3 TSDR Demethylation. | Kehrmann J et al. | β | 2011 | β |
| Gene expression in placentation of farm animals: an overview of gene function during development. | Barreto RS et al. | β | 2011 | β |
| Histone deacetylases in neural stem cells and induced pluripotent stem cells. | Sun G et al. | β | 2011 | β |
| Historical origins of transdifferentiation and reprogramming. | Graf T | β | 2011 | β |
| Increase developmental plasticity of human keratinocytes with gene suppression. | Li SC et al. | β | 2011 | β |
| Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia? | Liras A | β | 2011 | β |
| Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery. | Nsair A et al. | β | 2011 | β |
| In silico tandem affinity purification refines an Oct4 interaction list. | Cheong CY et al. | β | 2011 | β |
| Investigating monogenic and complex diseases with pluripotent stem cells. | Zhu H et al. | β | 2011 | β |
| Lineage conversion of murine extraembryonic trophoblast stem cells to pluripotent stem cells. | Kuckenberg P et al. | β | 2011 | β |
| Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. | Subramanyam D et al. | β | 2011 | β |
| Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. | Kim KY et al. | β | 2011 | β |
| New approaches for the generation of induced pluripotent stem cells. | Sidhu KS | β | 2011 | β |
| Novel chemically defined approach to produce multipotent cells from terminally differentiated tissue syncytia. | Jung DW et al. | β | 2011 | β |
| OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. | You JS et al. | β | 2011 | β |
| Oxamflatin significantly improves nuclear reprogramming, blastocyst quality, and in vitro development of bovine SCNT embryos. | Su J et al. | β | 2011 | β |
| Pioneer transcription factors: establishing competence for gene expression. | Zaret KS et al. | β | 2011 | β |
| Pluripotency maintenance in mouse somatic cell nuclear transfer embryos and its improvement by treatment with the histone deacetylase inhibitor TSA. | Hai T et al. | β | 2011 | β |
| Pluripotent stem cells for the study of CNS development. | Petros TJ et al. | β | 2011 | β |
| Proteomics and pluripotency. | Brumbaugh J et al. | β | 2011 | β |
| Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. | Wang W et al. | β | 2011 | β |
| Recapitulation of the embryonic cardiovascular progenitor cell niche. | Schenke-Layland K et al. | β | 2011 | β |
| Reprogramming of mouse fibroblasts to an intermediate state of differentiation by chemical induction. | Park J et al. | β | 2011 | β |
| Simple and efficient method for generation of induced pluripotent stem cells using piggyBac transposition of doxycycline-inducible factors and an EOS reporter system. | Tsukiyama T et al. | β | 2011 | β |
| Sinonasal teratocarcinosarcoma with yolk sac elements: a neoplasm of somatic or germ cell origin? | Thomas J et al. | β | 2011 | β |
| Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate. | Yamaguchi S et al. | β | 2011 | β |
| Stem cells and cell therapies in lung biology and lung diseases. | Weiss DJ et al. | β | 2011 | β |
| Synergic reprogramming of mammalian cells by combined exposure to mitotic Xenopus egg extracts and transcription factors. | Ganier O et al. | β | 2011 | β |
| T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications. | Lluis F et al. | β | 2011 | β |
| The impact of epigenomics on future drug design and new therapies. | Hamm CA et al. | β | 2011 | β |
| The prospect of induced pluripotent stem cells for diabetes mellitus treatment. | Soejitno A et al. | β | 2011 | β |
| Toward transgene-free induced pluripotent stem cells: lessons from transdifferentiation studies. | Chua SJ et al. | β | 2011 | β |
| Transcriptional control of embryonic and induced pluripotent stem cells. | Guenther MG | β | 2011 | β |
| Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death. | Migliaccio G et al. | β | 2011 | β |
| X chromosome inactivation in human and mouse pluripotent stem cells. | Fan G et al. | β | 2011 | β |
| Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. | Liu L et al. | β | 2010 | β |
| A Drosophila chromatin factor interacts with the Piwi-interacting RNA mechanism in niche cells to regulate germline stem cell self-renewal. | Smulders-Srinivasan TK et al. | β | 2010 | β |
| Advances in reprogramming somatic cells to induced pluripotent stem cells. | Patel M et al. | β | 2010 | β |
| Advancing stem cell research with microtechnologies: opportunities and challenges. | Toh YC et al. | β | 2010 | β |
| An Oct4-centered protein interaction network in embryonic stem cells. | van den Berg DLC et al. | β | 2010 | β |
| Arabidopsis Histone Lysine Methyltransferases. | Pontvianne F et al. | β | 2010 | β |
| Ascl1a regulates MΓΌller glia dedifferentiation and retinal regeneration through a Lin-28-dependent, let-7 microRNA signalling pathway. | Ramachandran R et al. | β | 2010 | β |
| Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. | Mali P et al. | β | 2010 | β |
| Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. | Ohm JE et al. | β | 2010 | β |
| Can controlled cellular reprogramming be achieved using microRNAs? | Sun X et al. | β | 2010 | β |
| Cell plasticity in homeostasis and regeneration. | Galliot B et al. | β | 2010 | β |
| Chromatin plasticity in pluripotent cells. | Melcer S et al. | β | 2010 | β |
| c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. | Martinez-Fernandez A et al. | β | 2010 | β |
| Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro. | Tokumoto Y et al. | β | 2010 | β |
| Directing astroglia from the cerebral cortex into subtype specific functional neurons. | Heinrich C et al. | β | 2010 | β |
| DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. | Momcilovic O et al. | β | 2010 | β |
| DNA methylation and cellular reprogramming. | De Carvalho DD et al. | β | 2010 | β |
| DNA methylation in cell differentiation and reprogramming: an emerging systematic view. | Huang K et al. | β | 2010 | β |
| Domain-wide regulation of DNA replication timing during mammalian development. | Pope BD et al. | β | 2010 | β |
| Efficiencies and mechanisms of nuclear reprogramming. | Pasque V et al. | β | 2010 | β |
| Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus. | Novak A et al. | β | 2010 | β |
| Epigenetic control of Hox genes during neurogenesis, development, and disease. | Barber BA et al. | β | 2010 | β |
| Epigenetic control of neural precursor cell fate during development. | Hirabayashi Y et al. | β | 2010 | β |
| Epigenetic regulation of neurogenesis in the adult hippocampus. | Covic M et al. | β | 2010 | β |
| Epigenetics of the vascular endothelium. | Yan MS et al. | β | 2010 | β |
| Epigenetic stability increases extensively during Drosophila follicle stem cell differentiation. | Skora AD et al. | β | 2010 | β |
| Experimental approaches for the generation of induced pluripotent stem cells. | Sommer CA et al. | β | 2010 | β |
| Five classic articles in somatic cell reprogramming. | Park IH | β | 2010 | β |
| Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. | Liras A | β | 2010 | β |
| High-efficiency somatic reprogramming induced by intact MII oocytes. | Yang H et al. | β | 2010 | β |
| Hooking up with Oct4. | Lemischka IR | β | 2010 | β |
| Induced pluripotency: history, mechanisms, and applications. | Stadtfeld M et al. | β | 2010 | β |
| Inducible pluripotent stem cells: not quite ready for prime time? | Robbins RD et al. | β | 2010 | β |
| iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. | Ramos-Mejia V et al. | β | 2010 | β |
| Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors. | Kane NM et al. | β | 2010 | β |
| Linking cell signaling and the epigenetic machinery. | Mohammad HP et al. | β | 2010 | β |
| Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. | Peric-Hupkes D et al. | β | 2010 | β |
| Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. | Liao JL et al. | β | 2010 | β |
| Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells. | Bapat SA et al. | β | 2010 | β |
| Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. | Sarig R et al. | β | 2010 | β |
| Myc transcription factors: key regulators behind establishment and maintenance of pluripotency. | Smith K et al. | β | 2010 | β |
| Myoblast-derived neuronal cells form glutamatergic neurons in the mouse cerebellum. | Gopalakrishnan V et al. | β | 2010 | β |
| No evidence for clonal selection due to lentiviral integration sites in human induced pluripotent stem cells. | Winkler T et al. | β | 2010 | β |
| Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. | Melton C et al. | β | 2010 | β |
| Physiological cellular reprogramming and cancer. | Abollo-JimΓ©nez F et al. | β | 2010 | β |
| Pluripotency maintenance mechanism of embryonic stem cells and reprogramming. | Masui S | β | 2010 | β |
| Regeneration and reprogramming compared. | Christen B et al. | β | 2010 | β |
| Stem cell biology and cell transplantation therapy in the retina. | Osakada F et al. | β | 2010 | β |
| Stem cell microenvironments--unveiling the secret of how stem cell fate is defined. | Votteler M et al. | β | 2010 | β |
| Stem cell transplantation in multiple sclerosis: current status and future prospects. | Martino G et al. | β | 2010 | β |
| Strategies for the derivation of pluripotent cells from farm animals. | Kues WA et al. | β | 2010 | β |
| Telomere rejuvenation during nuclear reprogramming. | MariΓ³n RM et al. | β | 2010 | β |
| Temporal anatomy of an epigenetic switch in cell programming: the white-opaque transition of C. albicans. | Lohse MB et al. | β | 2010 | β |
| The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells. | Tat PA et al. | β | 2010 | β |
| The four reprogramming factors and embryonic development in mice. | Yan X et al. | β | 2010 | β |
| The placenta: transcriptional, epigenetic, and physiological integration during development. | Maltepe E et al. | β | 2010 | β |
| Visualization of DNA methylation and histone modifications in living cells. | Kimura H et al. | β | 2010 | β |
| When fibroblasts MET iPSCs. | Polo JM et al. | β | 2010 | β |
| An uphill battle toward pluripotency. | Graf T | β | 2009 | β |
| Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. | Eminli S et al. | β | 2009 | β |
| Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. | VandenDriessche T et al. | β | 2009 | β |
| Epigenetic regulatory mechanisms during preimplantation development. | Corry GN et al. | β | 2009 | β |
| Erythroid cells in vitro: from developmental biology to blood transfusion products. | Migliaccio AR et al. | β | 2009 | β |
| Forcing cells to change lineages. | Graf T et al. | β | 2009 | β |
| Genetic and epigenetic control of early mouse development. | Albert M et al. | β | 2009 | β |
| gPS navigates germ cells to pluripotency. | Geijsen N et al. | β | 2009 | β |
| Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. | Utikal J et al. | β | 2009 | β |
| Induced human pluripotent stem cells: promises and open questions. | Rolletschek A et al. | β | 2009 | β |
| Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. | Chin MH et al. | β | 2009 | β |
| [Induced pluripotent stem cells (iPS cells)]. | Germain D | β | 2009 | β |
| Induced pluripotent stem cells: it's like dΓ©jΓ vu all over again. | Schenke-Layland K et al. | β | 2009 | β |
| Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. | Barzilay R et al. | β | 2009 | β |
| iPS cells: insights into basic biology. | Ramalho-Santos M | β | 2009 | β |
| iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. | Martinez-Fernandez A et al. | β | 2009 | β |
| Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming. | Wei Z et al. | β | 2009 | β |
| Members of the GCN5 histone acetyltransferase complex regulate PLETHORA-mediated root stem cell niche maintenance and transit amplifying cell proliferation in Arabidopsis. | Kornet N et al. | β | 2009 | β |
| MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century. | Matushansky I et al. | β | 2009 | β |
| Myc's other life: stem cells and beyond. | Laurenti E et al. | β | 2009 | β |
| Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors. | Balasubramanian S et al. | β | 2009 | β |
| Pancreatic neurogenin 3-expressing cells are unipotent islet precursors. | Desgraz R et al. | β | 2009 | β |
| [Pluripotency: defining standards]. | Coulombel L | β | 2009 | β |
| Polycomb group proteins: navigators of lineage pathways led astray in cancer. | Bracken AP et al. | β | 2009 | β |
| Progress toward effective treatments for human photoreceptor degenerations. | Stone EM | β | 2009 | β |
| Resetting the epigenome beyond pluripotency in the germline. | Hayashi K et al. | β | 2009 | β |
| Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. | Utikal J et al. | β | 2009 | β |
| Stem cells, stress, metabolism and cancer: a drama in two Octs. | Kang J et al. | β | 2009 | β |
| Stem cells: The root of all cells. | Terpstra I et al. | β | 2009 | β |
| The stem cell--chromatin connection. | Sang Y et al. | β | 2009 | β |
| The transcriptional foundation of pluripotency. | Chambers I et al. | β | 2009 | β |
| Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. | Kaufman DS | β | 2009 | β |
| Transcriptional competence in pluripotency. | Ram EV et al. | β | 2009 | β |
| Understanding the mysteries of iPS cells. | Cohen JB et al. | β | 2009 | β |
| Watching reprogramming in real time. | Subramanyam D et al. | β | 2009 | β |
| What is stemness? | Leychkis Y et al. | β | 2009 | β |